At ASHG 2025 held in Boston, I presented our latest research: leveraging complex disease genetics and evolution to dissect cross-ancestry genetics, selection, pleiotropy, aDNA introgression, and G*E🌹
Hope run a half marathon next time—the conference really cut running! 😄
Equity in human genetics research requires balanced participation not only from study participants from global populations but also from the researchers who drive the science.
🧵2/8
GDP and Nature Index Share, representing the economic and scientific capacity, respectively, were identified as key determinants of the average number of abstracts and oral presentations.
🧵7/8
At the European Society of Human Genetics (ESHG 2025) held in Milan, I presented our latest research progress: leveraging complex disease genetics and evolutionary genomics to investigate the genetic circuits of complex diseases and putative therapeutic targets. 🌹🌹🌹
🔥 OUT TODAY @NatureGenet
📰 Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci
🧑🏿🤝🧑🏻 Xikun Han, Puya Gharahkhani and colleagues
👇🏼
https://t.co/PHKrJIpKCm
We use automated AI labelling of 280,000 optic nerve images to dramatically improve gene mapping power for glaucoma and enable new insights into cross-ancestry glaucoma risk. @uk_biobank@clsa_elcv@GWAS_lit@biorxiv_genetic @QIMRBerghofer @UQMedicine @GLAUCOMA
I have been incredibly lucky during the PhD journey to work with Stuart, and greatly appreciate the amazing mentorship -- supportive, friendly and approachable.
The amazing Xikun Han @XikunH heads off to Harvard soon for his postdoc. Best of luck Xikun - congratulations on a series of excellent papers from your PhD (16 published to date, with more pending).
The folks at GoogleHealth have applied a ML approach to optic nerve measures, resulting in increased power for GWAS. They use a different training set, but their results compare well with the ones we derived in conjunction with @maxkelsen https://t.co/cj4uDxIAHg
We use automated AI labelling of 280,000 optic nerve images to dramatically improve gene mapping power for glaucoma and enable new insights into cross-ancestry glaucoma risk. @uk_biobank@clsa_elcv@GWAS_lit@biorxiv_genetic @QIMRBerghofer @UQMedicine @GLAUCOMA
The MYOC p.Gln368Ter variant has a high penetrance in OHT and #glaucoma. Our study suggests the need for early screening and identification of p.Gln368Ter carriers to prevent the progression of glaucoma. https://t.co/hRPsujI23e